Acceptability and Efficacy of Purified Vero-Cell Rabies Vaccine in Thai Children Exposed to Rabies

Abstract

A field trial of purified vero-cell tissue culture rabies vaccine (PVRV) was carried out, and 566 children under 15 years of age were studied. Of these 309 (54.6%) had been exposed to laboratory proven rabid animals. Rabies immune globulin (RIG) was given to 47 children with severe exposures. The vaccine was given by the conventional six-dose intramuscular route to 467 patients (82.5%). The remaining 99 victims (17.5%) were given vaccine by the multiple site intradermal route using a schedule of 0.1 ml at two sites on days 0, three and seven, and at one site on days 30 and 90. Adequate follow-up was achieved in 100% of the cases with proven exposure to rabid animals at three months, and in 94.1% at one year. The overall follow-up rate for the entire group was 91.1% at the end of one year, and all patients traced were alive and healthy. The incidence of minor adverse reactions to PVRV was equal to that of other tissue culture rabies vaccines. Regional lymphadenopathy and itching at the injection sites were significantly more common in the group receiving intradermal vaccine than in those who received vaccine by the intramuscular route.

Keywords

Post-Exposure Rabies Vaccine Purified Vero-Cell Rabies Vaccine Rabies vaccine efficacy Rabies vaccine intradermal Rabies vaccine side-effects

Get full access to this article

View all access options for this article.

References

1. Suntharasamai P , Warrell DA , Looareesuwan S et al: New purified vero-cell vaccine prevents rabies in patients bitten by rabid animals. Lancet 1986;i:129–31.

2. Suntharasamai P , Chanthavanich P , Warrell, MJ et al: Purified vero-cell rabies vaccine and human diploid cell strain vaccine. Comparison of neutralizing antibody responses to post-exposure regimen. J Hyg Camb 1986;96:483–9.

3. Phanuphak P , Khawplod P , Sirivichayakul S et al: Humoral and cell-mediated immune responses to various economical regimens of purified vero-cell rabies vaccine. Asian Pacific J Allergy Immunol 1987;5:33–7.

4. Chutivongse S , Supich C , Sumbooonnanondha A : Adverse effects of vero-cell rabies vaccine, preliminary field trial. Proc. International Virology Conference, Dec 1986, Bangkok.

5. Baer G : The Natural History of Rabies. New York: Academic Press, 1975.

6. Sitthi-Amorn C , Jiratanavattana J , Sonpunya N : The diagnostic properties of laboratory tests for rabies. Int J Epidemiol 1987;16:1–4.

7. Wasi C , Choomkasien P et al: Human Rabies cases after tissue culture rabies vaccine, Thailand 1983–1987. Virus Info Exchange Newsletter 1987;4:1–22.

8. Warrell MJ , Sutharasamai P , Sinhaseni A et al: An economical regimen of human diploid cell strain anti rabies vaccine for postexposure prophylaxis. Lancet 1983;ii:301–4.

9. Wasi C , Chaiprasithikul P , Chavanich L et al: Purified chicken embryo cell rabies vaccine. Lancet 1986;i:40.